BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38290824)

  • 1. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
    Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
    J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
    Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
    Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
    Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
    J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
    [No Abstract]   [Full Text] [Related]  

  • 4. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Codon 146
    Beyens A; Dequeker L; Brems H; Janssens S; Syryn H; D'Hooghe A; De Paepe P; Vanwalleghem L; Stockman A; Vankwikelberge E; De Schepper S; Goeteyn M; Delbeke P; Callewaert B
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
    J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
    Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
    Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype/genotype correlations in epidermal nevus syndrome as a neurocristopathy.
    Flores-Sarnat L; Sarnat HB
    Handb Clin Neurol; 2015; 132():9-25. PubMed ID: 26564069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocytic epidermal nevi associated with localized fibro-osseous lesions without hypophosphatemia.
    Mestach L; Polubothu S; Calder A; Denayer E; Gholam K; Legius E; Levtchenko E; Van Laethem A; Brems H; Kinsler VA; Morren MA
    Pediatr Dermatol; 2020 Sep; 37(5):890-895. PubMed ID: 32662096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.
    Prieto-Barrios M; Llamas-Martin R; Velasco-Tamariz V; Calleja-Algarra A; Ruano Y; Ortiz-Romero PL; Rodriguez-Peralto JL
    Br J Dermatol; 2018 Nov; 179(5):1163-1167. PubMed ID: 29430633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.
    Gadea A; Hernández-Muñoz I; Vicente A; Andrades E; García-Calvente M; Camacho L; Fernandez-Rodríguez C; Bellosillo B; Pujol R; Toll A
    J Med Genet; 2020 Sep; 57(9):601-604. PubMed ID: 31937562
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
    Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
    Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
    Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
    Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations.
    Theiler M; Weibel L; Christen-Zaech S; Carmignac V; Sorlin A; Neuhaus K; Chevarin M; Thauvin-Robinet C; Philippe C; Faivre L; Vabres P; Kuentz P
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2085-2090. PubMed ID: 33930231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
    Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.
    Avitan-Hersh E; Tatur S; Indelman M; Gepstein V; Shreter R; Hershkovitz D; Brick R; Bergman R; Tiosano D
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E132-6. PubMed ID: 24243633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phacomatosis pigmentokeratotica: a patient with the rare melanocytic-epidermal twin nevus syndrome.
    Hermes B; Cremer B; Happle R; Henz BM
    Dermatology; 1997; 194(1):77-9. PubMed ID: 9031800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
    Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
    Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal nevus syndromes.
    Asch S; Sugarman JL
    Handb Clin Neurol; 2015; 132():291-316. PubMed ID: 26564089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.